“Enzo Biochem, a New York-based biotechnology company, has confirmed that a ransomware attack exposed the clinical test information of almost 2.5 million patients. “
“Enzo, which manufactures and sells DNA-based tests to detect viral and bacterial diseases including COVID-19 and cancer, confirmed in an SEC filing this week that it experienced a ransomware attack on April 6. While it was able to remain operational by disconnecting its systems from the internet, Enzo said it discovered on April 11 that hackers were able to access and exfiltrate sensitive data from the company’s systems. “
“This includes clinical test information of 2,470,000 individuals and approximately 600,000 Social Security numbers, according to Enzo. The company added that it continues to investigate whether its employees’ information may have also been accessed. “
Cyber-Protecting Our Nation’s Critical Infrastructure
At SecuLore, our mission is to cyber-protect our nation’s critical infrastructure. Led by experts in 9-1-1 technology, cyberwarfare, and ethical hacking, our team provides the technology, expertise, and training needed to defend customers from increasingly sophisticated cyber threats.
